Literature DB >> 6190397

Clinical diversity of sickle cell anemia: genetic and cellular modulation of disease severity.

M H Steinberg, R P Hebbel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6190397     DOI： 10.1002/ajh.2830140412

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  13 in total

1.  Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.

Authors:  Mehdi Nouraie; Noel S Reading; Andrew Campbell; Caterina P Minniti; Sohail R Rana; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

Review 2.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

Review 3.  Nutritional support in sickle cell anemia: theoretical considerations.

Authors:  C O Enwonwu
Journal:  J Natl Med Assoc       Date:  1988-02       Impact factor: 1.798

Review 4.  Osteoarticular manifestations in sickle-cell disorders.

Authors:  P Kaklamanis
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

5.  Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.

Authors:  Christopher J Bean; Sheree L Boulet; Genyan Yang; Amanda B Payne; Nafisa Ghaji; Meredith E Pyle; W Craig Hooper; Pallav Bhatnagar; Jeffrey Keefer; Emily A Barron-Casella; James F Casella; Michael R Debaun
Journal:  Br J Haematol       Date:  2013-08-16       Impact factor: 6.998

6.  An Experimental-Computational Approach to Quantify Blood Rheology in Sickle Cell Disease.

Authors:  Marisa S Bazzi; José M Valdez; Victor H Barocas; David K Wood
Journal:  Biophys J       Date:  2020-10-20       Impact factor: 4.033

7.  Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients.

Authors:  Y M Yang; A K Shah; M Watson; V N Mankad
Journal:  Public Health Rep       Date:  1995 Jan-Feb       Impact factor: 2.792

8.  Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease.

Authors:  Poorya Hosseini; Sabia Z Abidi; E Du; Dimitrios P Papageorgiou; Youngwoon Choi; YongKeun Park; John M Higgins; Gregory J Kato; Subra Suresh; Ming Dao; Zahid Yaqoob; Peter T C So
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-10       Impact factor: 11.205

9.  A biophysical indicator of vaso-occlusive risk in sickle cell disease.

Authors:  David K Wood; Alicia Soriano; L Mahadevan; John M Higgins; Sangeeta N Bhatia
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

10.  Multiple complications in a sickle cell disease patient: a case report.

Authors:  J A Olaniyi
Journal:  Clin Med Case Rep       Date:  2008-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.